Study of Tislelizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer

⟵ Back to Search Results

Beigene Study ID

BGB-A317-204

ClinicalTrials.gov ID

NCT04004221

China Drug Trials ID

CTR20170071

Sex: All

Age: 18 Years and older (Adult, Older Adult)

No Study Documents

Sex: All

Age: 18 Years and older (Adult, Older Adult)

No Study Documents